Navigation Links
Data from FREEDOM-301 Study for LEVADEX™ Orally Inhaled Migraine Drug Published in 'Headache'
Date:4/7/2011

MOUNTAIN VIEW, Calif., April 7, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the publication of results from the Phase 3 FREEDOM-301 study of  LEVADEX™ orally inhaled migraine drug in the peer-reviewed journal 'Headache.' The manuscript, titled MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine, has been posted online and will appear in the April edition, Volume 51, Issue 4 of Headache: The Journal of Head and Face Pain. LEVADEX is an investigational acute therapy for migraine that has completed Phase 3 clinical development.

"There is general dissatisfaction with existing acute treatment options for migraine because of slow onset of action, inadequate pain relief, and high recurrence rates. Based on the results from the FREEDOM-301 study, LEVADEX has the potential to address many of the unmet needs of migraine sufferers," said Sheena Aurora, M.D., a FREEDOM-301 clinical study investigator, director of the Swedish Headache Center and assistant professor of neurology at the University Of Washington School of Medicine. 

In the FREEDOM-301 study, the efficacy assessment focused on the four major symptoms of migraine at the standard two hour time point for acute migraine studies. All four co-primary endpoints for LEVADEX were met at two hours:

  • Pain relief was observed in 59% of patients in the LEVADEX treatment group compared with 35% in the placebo group (p<0.0001)
  • Phonophobia free was observed in 53% of patients in the LEVADEX treatment group compared with 34% for the placebo group (p<0.0001)
  • Photophobia free was observed in 47% of patients in the LEVADEX treatment group compared with 27% for the placebo group (p<0.0001)
  • Nausea free was observed in 67% of  patients in the LEVADEX treatment group compared with 59% for the placeb
    '/>"/>

  • SOURCE MAP Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress
    2. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
    3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
    5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
    7. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    9. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
    10. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
    11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2014)... , July 31, 2014 For its ... California , Art,s-Way Scientific has earned a ... With competition in over 30 categories, MBI,s contest ... MBI members, which include building manufacturers, dealers, and product ... an excellent example the capability of our team," said ...
    (Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
    (Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
    Breaking Medicine Technology:Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
    ... 15 The U.S. Food and Drug Administration (FDA), ... Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered ... responsibility for criminal actions including distribution of an unapproved ... of an FDA inspection. (Logo:   ...
    ... 15 New England Biolabs (NEB) has announced ... of $1.22 million to fund the research and ... (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b) (Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b) ... developing tools that advance epigenetics research and discovery, ...
    Cached Medicine Technology:Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 3New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies 2
    (Date:7/31/2014)... 31, 2014 (HealthDay News) -- Many black women put ... new research. It,s estimated by the U.S. Centers ... five black women in the United States are overweight ... entirely to avoid having to have their hair restyled ... study authors said. However, the researchers also noted a ...
    (Date:7/31/2014)... published today in Genes & Development , ... Centre,s DNA Replication group, in collaboration with Brookhaven ... mechanisms involved in the enzyme that governs DNA ... system using synthetic, chemical and structural biology approaches, ... in duplicating genetic information embraces DNA through a ...
    (Date:7/31/2014)... LDM Global ( http://www.ldmglobal.com ) announces ... is simplified and predictable with fixed fees across the ... leading international provider of legal discovery management services for ... glaringly apparent that both the courts and legal counsel ... the complex pricing structure that plagues the litigation support ...
    (Date:7/31/2014)... 2014 The Alaska Center for ... new dentist Dr. Jonathan Oudin, DDS, who will begin ... in Barrow, Alaska, for three years. According to Teresa ... Dr. Oudin to help take on new patients. , ... continue growing and serving the greater Anchorage metro community," ...
    (Date:7/31/2014)... July 31, 2014 (HealthDay News) -- Transplant surgeons ... red flags for burnout, a new study suggests. ... the study reported having a low sense of ... to feeling emotionally exhausted, researchers found. "Burnout ... like transplantation," study co-author Dr. Marwan Abouljoud, director ...
    Breaking Medicine News(10 mins):Health News:Hairdo Trumps Exercise for Many Black Women, Study Finds 2Health News:Molecular gate that could keep cancer cells locked up 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2
    ... , MONDAY, Nov. 29 (HealthDay News) -- Genetics influence a ... have the greatest impact in the summer, the results of ... to maintain health and for strong bones, is naturally made ... not contain vitamin D unless it,s added by fortification. ...
    ... Children and teens who are overexposed to antibacterial soaps that ... hay fever and other allergies, a finding that suggests that ... The study also found that exposure to higher levels ... immune system. Triclosan is an antimicrobial agent widely used ...
    ... November 2010 Reduced male fertility may be making it ... low birth rates in many countries, reveals a new European ... 10% of couples worldwide are infertile, contributing to the growing ... (IVF) for which Robert G. Edwards won the Nobel Prize ...
    ... In a first-of-its-kind study to measure the impact of ... care unit, researchers at the University of Maryland School ... physicians and other health care professionals can enhance patient ... The results of the study have been released ...
    ... of people infected with HIV/AIDS in sub-Saharan Africa is ... the end of the decade, forcing African nations to ... of lifesaving antiretroviral therapy (ART), says a new report ... a renewed emphasis on reducing the rate of new ...
    ... A UCSF research collaboration with GE Healthcare has produced the ... to rapidly assess the presence and aggressiveness of prostate tumors ... is the first time researchers have used this technology to ... a revolutionary approach to assessing the precise outlines of a ...
    Cached Medicine News:Health News:Too Much Hygiene May Affect Immune System, Study Suggests 2Health News:Male reproductive problems may add to falling fertility rates 2Health News:More lives saved with 24/7 enhanced staffing in medical ICU 2Health News:More lives saved with 24/7 enhanced staffing in medical ICU 3Health News:More lives saved with 24/7 enhanced staffing in medical ICU 4Health News:Number of HIV/AIDS cases in sub-Saharan Africa expected to greatly outpace resources 2Health News:Number of HIV/AIDS cases in sub-Saharan Africa expected to greatly outpace resources 3Health News:New prostate cancer imaging shows real-time tumor metabolism 2Health News:New prostate cancer imaging shows real-time tumor metabolism 3Health News:New prostate cancer imaging shows real-time tumor metabolism 4
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: